- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pantoprazole Sodium 40 mg delayed-release tablets
Total 548 results
-
Ain Shams UniversityRecruitingDoxorubicin Induced CardiomyopathyEgypt
-
Ensysce BiosciencesPRA Health SciencesCompleted
-
Darnitsa Pharmaceutical CompanyInternational Pharmaceutical Research CenterCompleted
-
University of MichiganFood and Drug Administration (FDA)RecruitingHuman Gastrointestinal Physiology DataUnited States
-
Mylan Pharmaceuticals IncCompleted
-
Frederiksberg University HospitalCompleted
-
Mutual Pharmaceutical Company, Inc.Completed
-
Monash UniversityNational Health and Medical Research Council, AustraliaActive, not recruitingAging | Dementia, Vascular | Cognitive Decline | Dementia, Mixed | Neuro-Degenerative Disease | Dementia of Alzheimer Type | White Matter HyperintensityAustralia
-
AstraZenecaParexelCompletedType 2 Diabetes MellitusUnited States
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Diseases | Hypertension | Obesity | Nocturnal Blood Pressure | Natriuretic Peptides | Renin-Angiotensin-Aldosterone SystemUnited States
-
Actavis Inc.Completed
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 Diabetes Mellitus | Diabetic Kidney Disease | Adolescent Obesity | Puberty | Pre Diabetes | Kidney HypoxiaUnited States
-
PfizerCompleted
-
Miulli General HospitalNot yet recruitingHeart Failure | Obesity | Diabetes Mellitus | Atrial FibrillationItaly
-
Mylan Pharmaceuticals IncCompleted
-
Teva Pharmaceuticals USACompletedHealthyUnited States
-
Janssen Research & Development, LLCCompleted
-
Tanta UniversityActive, not recruiting
-
Impax Laboratories, LLCCompletedIdiopathic Parkinson's DiseaseUnited States
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaboratorsRecruitingGlucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin SensitivityNorway
-
Fundación Pública Andaluza para la Investigación...Unknown
-
Medical University of BialystokMedical Research Agency, PolandRecruitingSmoking | Copd | COPD Exacerbation | Gene Expression | AtorvastatinPoland
-
Ardea Biosciences, Inc.Completed
-
Cancer Research AntwerpBayer; Veracyte, Inc.Recruiting
-
Children's Mercy Hospital Kansas CityIndiana Clinical and Translational Sciences InstituteRecruitingFontan CirculationUnited States
-
LM Diagnósticos S.L.AstraZenecaUnknown
-
King Abdullah International Medical Research CenterCompleted
-
Larena SASRecruitingMelatonin BioavailabilityFrance
-
Boehringer IngelheimCompleted
-
PfizerCompleted
-
University of SaskatchewanAstraZenecaCompleted
-
International Bio serviceNot yet recruiting
-
Ain Shams UniversityRecruiting
-
University Health Network, TorontoRecruitingType 2 Diabetes | Kidney Transplant Recipients | Post-transplant Diabetes MellitusCanada
-
AbbottCompletedPediatric EpilepsyUnited States
-
UCB BIOSCIENCES GmbHEden SarlCompletedEpilepsy | MonotherapyUnited States, Australia, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Philippines, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Swede... and more
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Hospices Civils de LyonCompletedNeuropathic Pain | Complex Regional Pain Syndrome Type 1France
-
University of LeicesterAstraZeneca; Royal Surrey County Hospital NHS Foundation TrustCompletedThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes (SINGLED)Type 2 DiabetesUnited Kingdom
-
Valenta Pharm JSCRecruitingNauseaRussian Federation
-
Peter VestergaardAalborg UniversityCompletedPrimary Hyperparathyroidism | Parathyroid Adenoma | Parathyroid HyperplasiaDenmark
-
XenoPort, Inc.Completed
-
Bial - Portela C S.A.Terminated
-
Pharma NuevaNot yet recruiting
-
SandozCompleted
-
Shanghai Zhongshan HospitalActive, not recruiting
-
PharPoint Research, Inc.Withdrawn
-
SandozCompleted
-
Tris Pharma, Inc.Premier Research Group plcCompleted
-
BayerCompletedSeasonal Allergic Rhinitis | Vasomotor Rhinitis